• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

私募股权投资:好坏参半。

Private Equity: The Bad and the Ugly.

机构信息

Department of Dermatology, University of Florida College of Medicine, 4037 Northwest 86th Terrace, 4th Floor, Gainesville, FL 32606, USA.

Department of Dermatology, University of Florida College of Medicine, 4037 Northwest 86th Terrace, 4th Floor, Gainesville, FL 32606, USA.

出版信息

Dermatol Clin. 2023 Oct;41(4):597-610. doi: 10.1016/j.det.2023.04.004. Epub 2023 Jun 9.

DOI:10.1016/j.det.2023.04.004
PMID:37718017
Abstract

Private equity's (PE) presence has grown within dermatology over the last decade, creating a new landscape for dermatologists to navigate. Although dermatology PE-backed groups (DPEGs) claim to partner with physicians and improve health care delivery, their actions show that investment returns and profits are prioritized. The history of PE in medicine, the corporate practice of medicine, maturation of the dermatology market, monopolistic practices, overleveraging of nonphysician practitioners, dependence on debt, training under PE, and professional and lifestyle considerations are discussed. Dermatologists should be wary of DPEGs in order to protect the profession and patients.

摘要

过去十年,私募股权投资(PE)在皮肤病学领域的影响力不断增强,为皮肤科医生带来了新的挑战。尽管皮肤科私募股权投资集团(DPEG)声称与医生合作并改善医疗服务的提供,但他们的行为表明,投资回报和利润是优先考虑的。本文讨论了 PE 在医学领域的历史、公司化行医、皮肤病学市场的成熟、垄断行为、过度使用非医生从业者、对债务的依赖、在 PE 下的培训以及专业和生活方式的考虑。皮肤科医生应该警惕 DPEG,以保护自己的职业和患者的利益。

相似文献

1
Private Equity: The Bad and the Ugly.私募股权投资:好坏参半。
Dermatol Clin. 2023 Oct;41(4):597-610. doi: 10.1016/j.det.2023.04.004. Epub 2023 Jun 9.
2
Trends in Debt Valuations of Private Equity-Backed Dermatology Groups Before and During the COVID-19 Pandemic.私人股本支持的皮肤科集团在 COVID-19 大流行前后的债务估值趋势。
JAMA Dermatol. 2022 Apr 1;158(4):395-403. doi: 10.1001/jamadermatol.2022.0009.
3
Private equity in ophthalmology: taking the long view.眼科领域的私募股权:长远视角
Curr Opin Ophthalmol. 2023 Sep 1;34(5):390-395. doi: 10.1097/ICU.0000000000000976. Epub 2023 May 23.
4
Life cycle of private equity investments in physician practices: an overview of private equity exits.私募股权对医生执业机构投资的生命周期:私募股权退出概述
Health Aff Sch. 2024 Apr 10;2(4):qxae047. doi: 10.1093/haschl/qxae047. eCollection 2024 Apr.
5
The corporatization of care in academic dermatology.学术皮肤科护理的公司化。
Clin Dermatol. 2020 May-Jun;38(3):289-295. doi: 10.1016/j.clindermatol.2020.02.003. Epub 2020 Feb 19.
6
Financial Health of Private Equity-Backed Groups: Perspectives From Eye Care.私募股权支持集团的财务健康状况:来自眼保健行业的视角
Cureus. 2023 May 27;15(5):e39582. doi: 10.7759/cureus.39582. eCollection 2023 May.
7
The evolution of private equity in dermatology.皮肤科私募股权投资的演变。
Clin Dermatol. 2020 May-Jun;38(3):275-283. doi: 10.1016/j.clindermatol.2020.02.007. Epub 2020 Feb 19.
8
Trends in Private Equity Acquisition of Dermatology Practices in the United States.美国皮肤科诊所私募股权收购的趋势
JAMA Dermatol. 2019 Sep 1;155(9):1013-1021. doi: 10.1001/jamadermatol.2019.1634.
9
Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology.21 世纪美国政策改革背景下临床皮肤科的未来考量:皮肤科的公司化和私募股权的兴起。
J Am Acad Dermatol. 2019 Jul;81(1):287-296.e8. doi: 10.1016/j.jaad.2018.09.052. Epub 2018 Oct 5.
10
A Systematic Review: Landscape of Private Equity in Dermatology From Past to Present.系统性回顾:从过去到现在,皮肤病学领域的私募股权投资全景。
J Drugs Dermatol. 2023 Apr 1;22(4):404-409. doi: 10.36849/JDD.6892.